MTOR Inhibitors

The mammalian target of rapamycin (mTOR) is a downstream mediator in the phos-phatidylinositol 3-kinase/Akt signaling pathway which controls translation of proteins that regulate cell growth and proliferation, but also angiogenesis and cell survival.


The mTOR is an intracellular component which stimulates protein synthesis by phos-phorylating translation regulators, and contributes to protein degradation and an-giogenesis. Temsirolimus is approved for the treatment advanced renal cell carcinoma. The pharmacokinetics of temsirolimus are best described by a two-compartment mod el, with a terminal half-life of 13 to 25 hours. Elimination is primarily via the feces. Temsirolimus, and its metabolite sirolimus, are substrates of the cytochrome P4503A4/5 isoenzyme system. The primary side effects of temsirolimus include mucositis, diarrhea, maculopapular rash, nausea, leucopenia, thrombocytopenia, and hy-perglycemia.

The Prevention and Treatment of Headaches

The Prevention and Treatment of Headaches

Are Constant Headaches Making Your Life Stressful? Discover Proven Methods For Eliminating Even The Most Powerful Of Headaches, It’s Easier Than You Think… Stop Chronic Migraine Pain and Tension Headaches From Destroying Your Life… Proven steps anyone can take to overcome even the worst chronic head pain…

Get My Free Audio Book

Post a comment